Antipsychotics side effects' influence on stigma of mental illness: Focus group study results

Psychiatria Danubina

Volumn 21, Issue 1, 2009, Pages 99-102

  Novak, Lan ^a   Švab, Vesna ^a  

^a Clinical Radiology Institute   (Slovenia)

Author keywords

Antipsychotics; Focus group; Schizophrenia; Side effects; Stigma

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; CLINICAL ARTICLE; CONCENTRATION LOSS; CONFERENCE PAPER; COORDINATION DISORDER; COPING BEHAVIOR; EMPLOYMENT DISCRIMINATION; FAMILY RELATION; FATIGUE; FEMALE; HUMAN; MALE; MENTAL DISEASE; MUSCLE RIGIDITY; PATIENT ATTITUDE; PERSONAL EXPERIENCE; QUALITY OF LIFE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STIGMA; THINKING IMPAIRMENT; WORK DISABILITY;

ADULT; ANTIPSYCHOTIC AGENTS; EMPLOYMENT; FAMILY RELATIONS; FEMALE; FOCUS GROUPS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREJUDICE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF DISCLOSURE; STEREOTYPING;

EID: 63649110823     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Bebbington P & Kuipers L: The predictive Utility of Expressed Emotion in Schizophrenia: An Aggregate Analysis. Psychological Medicine, 1994; 24: 1-11.
2. Freudenreich O, Cather C, Evins AE, Henderson DC & Goff DC: Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. Journal of Clinical Psychiatry, 2004; 65: 1372-6.
3. Haddad PM & Sharma SG: Adverse effects of aty pical antipsychotics: differential risk and clinical implications. CNSDrugs, 2007; 21: 911-36.
4. Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JR, Thapa P & Sullivan G: A pilot study of barriers to medication adherence in schizophrenia. Journal of Clinical Psychiatry. 2004; 65: 211-216.
5. Jenkins JH & Carpenter-Song E: The new paradigm of recovery from schizophrenia: cultural conundrums of improvement without cure. Culture, Medicine and Psychiatry, 2006; 29: 379-413.
6. Jenkins JH, Strauss ME, Carpenter EA, Miller D, Floersch J & Sajatovic M: Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics. International journal of social psychiatry, 2005; 51: 211-227.
7. Kruger RA: Focus groups: a practical guide to applied research. Thousand Oaks, CA: Sage Publications, 1994.
8. Lee S, Chiu MYL, Tsang A, Chui H & Kleinman A: Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Hong Kong. Social Science & Medicine, 2002; 62: 1685-1696.
9. Marwaha S & Johnson S: Schizophrenia and employment. Social Psychiatry and Psychiatric Epidemiology, 2004; 39: 337-349.
10. Rudge T & Morse K: Did anything change? Caregivers and schizophrenia after medication changes. Journal of Psychiatric and Mental Health Nursing 2004; 11: 3-11.
11. Ruetsch O, Viala A, Bardou H, Martin P & Vacheron MN: Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management. Encephale, 2005; 31: 507-16.12 Sajatovic M & Jenkins JH: Is antipsychotic medication stigmatizing for people with mental illness? International Review of Psychiatry, 2007; 19: 107-112.
12. Schulze B & Angermeyer M: Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Social Science & Medicine, 2003; 56: 299-312.
13. Steward D & Shamdasani P: Focus groups: Theory and practice. Applied Social Research Method Series. Newbury Park: Sage Publications, 1994.
14. Tandon R. & Jibson MD: Extrapyramidal side effects of antipsychotic treatment: Scope of problem and impact of outcome. Annals of Clinical Psychiatry, 2002; 14: 123-129.
15. Thompson AH, Stuart H, Bland RC, Arboleda-Florez J, Warner R & Dickson AR: Attitudes about schizophrenia from the pilot site of the WPA worldwide campaign against the stigma of schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 2002; 37: 475-482.